Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2015 (2015), Article ID 127828, 12 pages
http://dx.doi.org/10.1155/2015/127828
Research Article

Inhibitory and Apoptosis-Inducing Effects of Newcastle Disease Virus Strain AF2240 on Mammary Carcinoma Cell Line

1Research Laboratory of Anatomy & Histology, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia (UPM), 43400 Serdang, Selangor, Malaysia
2Department of Human Anatomy, Faculty of Medicine, Bauchi State University, PMB 65, Gadau, Nigeria
3Department of Human Anatomy, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia (UPM), 43400 Serdang, Selangor, Malaysia

Received 29 October 2014; Revised 5 February 2015; Accepted 5 February 2015

Academic Editor: Hirotaka Iwase

Copyright © 2015 Umar Ahmad et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. K. McPherson, C. M. Steel, and J. M. Dixon, “ABC of breast diseases: breast cancer—epidemiology, risk factors, and genetics,” British Medical Journal, vol. 321, no. 7261, pp. 624–628, 2000. View at Publisher · View at Google Scholar · View at Scopus
  2. W. Burke, M. Daly, J. Garber et al., “Recommendations for follow-up care of individuals with an inherited predisposition to cancer: II. BRCA1 and BRCA2,” The Journal of the American Medical Association, vol. 277, no. 12, pp. 997–1003, 1997. View at Publisher · View at Google Scholar · View at Scopus
  3. N. Loman, O. Johannsson, U. Kristoffersson, H. Olsson, and Å. Borg, “Family history of breast and ovarian cancers and BRCA1 and BRCA2 mutations in a population-based series of early-onset breast cancer,” Journal of the National Cancer Institute, vol. 93, no. 16, pp. 1215–1223, 2001. View at Publisher · View at Google Scholar · View at Scopus
  4. A. Goldhirsch, W. C. Wood, R. D. Gelber, A. S. Coates, B. Thürlimann, and H.-J. Senn, “Meeting highlights: updated international expert consensus on the primary therapy of early breast cancer,” Journal of Clinical Oncology, vol. 21, no. 17, pp. 3357–3365, 2003. View at Publisher · View at Google Scholar · View at Scopus
  5. L. You, B. He, Z. Xu, F. McCormick, and D. M. Jablons, “Future directions: uncolytic viruses,” Clinical Lung Cancer, vol. 5, no. 4, pp. 226–230, 2004. View at Publisher · View at Google Scholar · View at Scopus
  6. B. Everts and H. G. van der Poel, “Replication-selective oncolytic viruses in the treatment of cancer,” Cancer Gene Therapy, vol. 12, no. 2, pp. 141–161, 2005. View at Publisher · View at Google Scholar · View at Scopus
  7. K. Yusoff and W. S. Tan, “Newcastle disease virus: macromolecules and opportunities,” Avian Pathology, vol. 30, no. 5, pp. 439–455, 2001. View at Publisher · View at Google Scholar · View at Scopus
  8. F. Fenner, P. Bachmann, E. Gibbs, F. Murphym, and D. W. Studdert, Veterinary Virology, Academic Press, Orlando, Fla, USA, 1987.
  9. J. G. Sinkovics and J. C. Horvath, “Newcastle disease virus (NDV): brief history of its oncolytic strains,” Journal of Clinical Virology, vol. 16, no. 1, pp. 1–15, 2000. View at Google Scholar · View at Scopus
  10. A. D. Hartkopf, T. Fehm, D. Wallwiener, and U. M. Lauer, “Oncolytic virotherapy of breast cancer,” Gynecologic Oncology, vol. 123, no. 1, pp. 164–171, 2011. View at Publisher · View at Google Scholar · View at Scopus
  11. D. Zamarin and P. Palese, “Oncolytic Newcastle disease virus for cancer therapy: old challenges and new directions,” Future Microbiology, vol. 7, no. 3, pp. 347–367, 2012. View at Publisher · View at Google Scholar · View at Scopus
  12. L. K. Csatary, G. Gosztonyi, J. Szeberenyi et al., “MTH-68/H oncolytic viral treatment in human high-grade gliomas,” Journal of Neuro-Oncology, vol. 67, no. 1-2, pp. 83–93, 2004. View at Publisher · View at Google Scholar · View at Scopus
  13. B. Yaacov, E. Elihaoo, I. Lazar et al., “Selective oncolytic effect of an attenuated Newcastle disease virus (NDV-HUJ) in lung tumors,” Cancer Gene Therapy, vol. 15, no. 12, pp. 795–807, 2008. View at Publisher · View at Google Scholar · View at Scopus
  14. K. W. Reichard, R. M. Lorence, C. J. Cascino et al., “Newcastle disease virus selectively kills human tumor cells,” Journal of Surgical Research, vol. 52, no. 5, pp. 448–453, 1992. View at Publisher · View at Google Scholar · View at Scopus
  15. S. Anushia, Effect of Newcastle Disease Virus AF2240 on Allografted 4T1 Breast Cancer Cells in BALB/c Mice, Universiti Putra Malaysia, 2010.
  16. A. M. Alabsi, S. A. A. Bakar, R. Ali et al., “Effects of Newcastle disease virus strains AF2240 and V4-UPM on cytolysis and apoptosis of leukemia cell lines,” International Journal of Molecular Sciences, vol. 12, no. 12, pp. 8645–8660, 2011. View at Publisher · View at Google Scholar · View at Scopus
  17. M. M. Zulkifli, R. Ibrahim, A. M. Ali et al., “Newcastle diseases virus strain V4UPM displayed oncolytic ability against experimental human malignant glioma,” Neurological Research, vol. 31, no. 1, pp. 3–10, 2009. View at Publisher · View at Google Scholar · View at Scopus
  18. N. Meyyapan, Oncolytic Effect of Newcastle Disease Virus on the MCF-7 and MDA-MB-231 Breast Cancer Cell Lines, Universiti Putra Malaysia, 2003.
  19. A. M. Alabsi, R. Ali, A. Ideris et al., “Anti-leukemic activity of Newcastle disease virus strains AF2240 and V4-UPM in murine myelomonocytic leukemia in vivo,” Leukemia Research, vol. 36, no. 5, pp. 634–645, 2012. View at Publisher · View at Google Scholar · View at Scopus
  20. S. Tone, “Apoptosis and programmed cell death,” Human Cell, vol. 7, no. 1, pp. 6–12, 1994. View at Google Scholar · View at Scopus
  21. A. Saraste and K. Pulkki, “Morphologic and biochemical hallmarks of apoptosis,” Cardiovascular Research, vol. 45, no. 3, pp. 528–537, 2000. View at Publisher · View at Google Scholar · View at Scopus
  22. M. M. Compton, “A biochemical hallmark of apoptosis: internucleosomal degradation of the genome,” Cancer and Metastasis Reviews, vol. 11, no. 2, pp. 105–119, 1992. View at Publisher · View at Google Scholar · View at Scopus
  23. J. Vogel and A. Shelokov, “Adsorption-hemagglutination test for influenza virus in monkey kidney tissue culture,” Science, vol. 126, no. 3269, pp. 358–359, 1957. View at Google Scholar · View at Scopus
  24. P. Chambers and A. C. R. Samson, “A new structural protein for Newcastle disease virus,” Journal of General Virology, vol. 50, no. 1, pp. 155–166, 1980. View at Publisher · View at Google Scholar · View at Scopus
  25. T. Mosmann, “Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays,” Journal of Immunological Methods, vol. 65, no. 1-2, pp. 55–63, 1983. View at Publisher · View at Google Scholar · View at Scopus
  26. W. Strober, “Trypan blue exclusion test of cell viability,” Current Protocols in Immunology, 2001. View at Publisher · View at Google Scholar
  27. R. López-Marure, P. G. Contreras, and J. S. Dillon, “Effects of dehydroepiandrosterone on proliferation, migration, and death of breast cancer cells,” European Journal of Pharmacology, vol. 660, no. 2-3, pp. 268–274, 2011. View at Publisher · View at Google Scholar · View at Scopus
  28. S. Elankumaran, D. Rockemann, and S. K. Samal, “Newcastle disease virus exerts oncolysis by both intrinsic and extrinsic caspase-dependent pathways of cell death,” Journal of Virology, vol. 80, no. 15, pp. 7522–7534, 2006. View at Publisher · View at Google Scholar · View at Scopus
  29. D. Cervantes-García, R. Ortiz-López, N. Mayek-Pérez, and A. Rojas-Martínez, “Oncolytic virotherapy,” Annals of Hepatology, vol. 7, no. 1, pp. 34–45, 2008. View at Google Scholar · View at Scopus
  30. R. Ali, A. M. Alabsi, A. M. Ali et al., “Cytolytic effects and apoptosis induction of Newcastle disease virus strain AF2240 on anaplastic astrocytoma brain tumor cell line,” Neurochemical Research, vol. 36, no. 11, pp. 2051–2062, 2011. View at Publisher · View at Google Scholar · View at Scopus
  31. A. M. Alabsi, R. Ali, A. Ideris et al., “Anti-leukemic activity of Newcastle disease virus strains AF2240 and V4-UPM in murine myelomonocytic leukemia in vivo,” Leukemia Research, vol. 36, no. 5, pp. 634–645, 2012. View at Publisher · View at Google Scholar · View at Scopus
  32. R. A. Saeed, Cytolytic Effects of Newcastle Disease Virus Strain AF2240 on DBTRG . 05MG AND U-87MG Brain Tumot Cell Lines, Universiti Putra Malaysia, Seri Kembangan, Malaysia, 2008.
  33. L. K. Csatary, R. W. Moss, J. Beuth, B. Töröcsik, J. Szeberenyi, and T. Bakacs, “Beneficial treatment of patients with advanced cancer using a Newcastle Disease Virus Vaccine (MTH-68/H),” Anticancer Research, vol. 19, no. 1, pp. 635–638, 1999. View at Google Scholar · View at Scopus
  34. Z. Chai, P. Zhang, F. Fu et al., “Oncolytic therapy of a recombinant Newcastle disease virus D90 strain for lung cancer,” Virology Journal, vol. 11, no. 1, article 84, 2014. View at Publisher · View at Google Scholar · View at Scopus
  35. H. Fukuhara, Y. Homma, and T. Todo, “Oncolytic virus therapy for prostate cancer,” International Journal of Urology, vol. 17, no. 1, pp. 20–30, 2010. View at Publisher · View at Google Scholar · View at Scopus
  36. F. Othman, A. Ideris, G. Motalleb, Z. B. Eshak, and A. Rahmat, “Oncolytic effect of Newcastle disease virus AF2240 strain on the MCF-7 breast cancer cell line,” Yakhteh Medical Journal, vol. 12, no. 1, pp. 17–24, 2010. View at Google Scholar
  37. Z. Darzynkiewicz, D. Galkowski, and H. Zhao, “Analysis of apoptosis by cytometry using TUNEL assay,” Methods, vol. 44, no. 3, pp. 250–254, 2008. View at Publisher · View at Google Scholar · View at Scopus
  38. T. Tamura, S. Said, W. Lu, and D. Neufeld, “Specificity of TUNEL method depends on duration of fixation,” Biotechnic and Histochemistry, vol. 75, no. 4, pp. 197–200, 2000. View at Publisher · View at Google Scholar · View at Scopus
  39. M. Kelly and M. F. MacNicol, “Identification of the saphenous nerve at arthroscopy,” Arthroscopy, vol. 19, no. 5, pp. 1–2, 2003. View at Publisher · View at Google Scholar · View at Scopus
  40. M. Mahadi, Cellular apoptosis of 4T1 breast cncer cells induced by V4-UPM newcastle disease virus [M.S. thesis], Universiti Putra Malaysia, Seri Kembangan, Malaysia, 2007.
  41. X. Li and Z. Darzynkiewicz, “Labelling DNA strand breaks with BrdUTP. Detection of apoptosis and cell proliferation,” Cell Proliferation, vol. 28, no. 11, pp. 571–579, 1995. View at Publisher · View at Google Scholar · View at Scopus
  42. P. Pozarowski and Z. Darzynkiewicz, “Analysis of cell cycle by flow cytometry,” Methods in Molecular Biology, vol. 281, pp. 301–311, 2004. View at Google Scholar · View at Scopus
  43. D. Tao, J. Wu, Y. Feng, J. Qin, J. Hu, and J. Gong, “New method for the analysis of cell cycle-specific apoptosis,” Cytometry Part A, vol. 57, no. 2, pp. 70–74, 2004. View at Google Scholar · View at Scopus